Table 1 Study participant characteristics
From: Development and validation of a prognostic score during tuberculosis treatment
Characteristics | Included patients N = 2250 (%) | Excluded patients N = 1119 (%) | p |
|---|---|---|---|
Gender | |||
Male | 1286 (57.2) | 742 (66.3) | <0.001 |
Female | 964 (42.8) | 377 (33.7) | |
Age, mean (SD) | 35.8 (12.7) | 36.7 (13.4) | 0.144 |
Initial hospitalization | |||
Yes | 1363 (60.6) | 495 (45.3) | <0.001 |
No | 887 39.4) | 597 (54.7) | |
Clinical form | |||
PTB+ | 1527 (67.9) | 724 (64.9) | 0.008 |
PTB− | 210 (9.3) | 143 (12.8) | |
ETB | 513 (22.8) | 248 (22.2) | |
Type of patient | |||
New cases | 2119 (94.2) | 1037 (92.7) | 0.129 |
Retreatment | 106 (4.7) | 71 (6.3) | |
Other | 25 (1.1) | 11 (1.0) | |